So I have taken a bit of a kicking, as I rightly did not comment on the long-term experience with rituximab in non-MS conditions and cancer is not a particular problem, so I do not want to scare you. However I can go back to ocrelizumab and give you thier take and the risks of cancer are small and that is the case for Breast cancer too. As you can see in many ways the risks are no different from life.
In brief this shows that there risks of cancer are small and similar to “Life”
CoI Multiple and I have done talks for Roche,